Satellos Bioscience (NASDAQ:MSLE – Get Free Report) was upgraded by investment analysts at Zacks Research to a “hold” rating in a report released on Tuesday,Zacks.com reports.
Satellos Bioscience Stock Performance
Further Reading
- Five stocks we like better than Satellos Bioscience
- Is THIS the Next Big Money Rush?
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Is Elon Preparing for a Silver Shock?
Receive News & Ratings for Satellos Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Satellos Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
